CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- 4 Open-market sale SVP Clinical Development, CMO sold 2,000 shares at $13.00 ($26,000)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP Clinical Development, CMO sold 2,000 shares at $15.57 ($31,140)
- 8-K Event Material agreement · Shareholder vote results · Other events
- 424B5 Offering Prospectus
- 8-K Event Agreement ended
Page 25 of 34 · 678 filings